Company Overview

HAEMONETICS CORP

HAE
Annual
Revenue vs. Cost of Revenue
Revenue Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses Operating Income
Net Income
Net Income
Revenue
—M
2024 FY
Net Income
168M
2024 FY
Shares Outstanding
50M
2024 FY
EPS
3.33USD
2024 FY
Company Information
SIC Code
3841
CIK Code
313143
Exchange
NYSE
Location
US